Mylan Investors Slam Tax Inversion As Anti-Teva Ploy
A Mylan NV shareholder sued the pharmaceutical company, its CEO and a board member in Pennsylvania federal court Tuesday, claiming the leaders improperly concealed the circumstances of a tax inversion and...To view the full article, register now.
Already a subscriber? Click here to view full article